Importantly, a recent study using pharmacological activators of K+ channels in SCA1 mice found that targeting dendritic excitability was important for producing sustained motor improvement, arguing for the importance of addressing increased dendritic excitability in ataxia [42]. Here, ATXN1 is linked to Ataxia.